| __timestamp | BeiGene, Ltd. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 6930000 | 2999000 |
| Thursday, January 1, 2015 | 7311000 | 10393000 |
| Friday, January 1, 2016 | 20097000 | 15994000 |
| Sunday, January 1, 2017 | 62602000 | 26975000 |
| Monday, January 1, 2018 | 195385000 | 39509000 |
| Tuesday, January 1, 2019 | 388249000 | 48869000 |
| Wednesday, January 1, 2020 | 600176000 | 42510000 |
| Friday, January 1, 2021 | 990123000 | 46105000 |
| Saturday, January 1, 2022 | 1277852000 | 50513000 |
| Sunday, January 1, 2023 | 1504501000 | 51292000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. BeiGene, Ltd. and Wave Life Sciences Ltd. offer a fascinating study in contrasts. Over the past decade, BeiGene's SG&A expenses have surged by over 21,000%, from approximately $7 million in 2014 to $1.5 billion in 2023. This reflects its aggressive expansion and investment in global operations. In contrast, Wave Life Sciences has maintained a more conservative growth, with SG&A costs increasing by about 1,600% over the same period, reaching around $51 million in 2023. This disparity highlights BeiGene's rapid scaling strategy compared to Wave's more measured approach. Investors and industry watchers should consider these trends when evaluating the operational efficiency and strategic direction of these companies.
Selling, General, and Administrative Costs: Biogen Inc. vs Wave Life Sciences Ltd.
BeiGene, Ltd. and Genmab A/S: SG&A Spending Patterns Compared
BeiGene, Ltd. and Ascendis Pharma A/S: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Arrowhead Pharmaceuticals, Inc.
BeiGene, Ltd. vs Vericel Corporation: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Selling, General, and Administrative Costs: Alkermes plc vs Wave Life Sciences Ltd.
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared